Stryker | SYK - Frais De Vente Et D'Administration

Prix De L'Action
327.51
Variation Quotidienne
-2.14 -0.65%
Mensuellement
-0.04%
Annuel
-10.29%
Q2 Prévisions
335.77




Frais De Vente Et D'Administration Changement Date
Abbott USD 3.27B 138M 2026-03
AtriCure USD 78.34M 109K 2025-12
Avanos Medical USD 78.8M 1.2M 2025-12
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
CONMED USD 166.76M 26.42M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Danaher USD 1.86B 166M 2026-03
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Globus Medical USD 318.48M 4.88M 2025-12
Haemonetics USD 109.15M 7.54M 2025-12
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
Intuitive Surgical USD 613.3M 73.8M 2026-03
J&J USD 6.03B 719M 2026-03
Masimo USD 128M 11.6M 2025-12
Medtronic 2.97B 159M 2025-09
Merit Medical Systems USD 114.83M 7.45M 2025-12
Olympus JPY 125.65B 5.75B 2025-12
Smith & Nephew USD 1.42B 65M 2025-12
Steris USD 352.3M 2.6M 2025-12
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Terumo JPY 105.26B 7.38B 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12